US Patent Issued to The Broad Institute, Massachusetts Institute of Technology on June 2 for "Delivery, use and therapeutic applications of CRISPR systems and compositions for genome editing as to hematopoietic stem cells (HSCs)" (Massachusetts Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,644,136, issued on June 2, was assigned to The Broad Institute Inc. (Cambridge, Mass.) and Massachusetts Institute of Technology (Cambridge, Mass.).

"Delivery, use and therapeutic applications of CRISPR systems and compositions for genome editing as to hematopoietic stem cells (HSCs)" was invented by David Benjamin Turitz Cox (Cambridge, Mass.), James E. Dahlman (Cambridge, Mass.) and Feng Zhang (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides for delivery, engineering and optimization of systems, methods, and compositions for manipulation of sequences and/or activities of target sequences. Provided are delivery sys...